agree with jasonaz
in any loan transaction , especially with a company with no revenues , silicon valley has more access to insider info than inst/retail holders.
to ammend the debt agreement raises a ? that there is a deal about to happen soon.
are they waiting for the new ceo ? could be.
what will the enrollment #s be for the fourth quarter ?
I doubt the volume in the past 2 weeks is major volume that someone is running away. more of an accumulation.
If this goes bust ill put my hands up. but if hopefully it is successful , buying at these levels and at $2 will be the best decision i made.
and funds arent readily available im practically liquidating some assets just to add more.
my average was probably $9 its $6 now so im still far off , but happy with my holding.
you have a chance to either risk more and double your holding or continue the ride and you either lose it all or regain your investment if things go back to $7-10.
im with semi and xc , id rather buy more when i can as I still believe in this product and the market potential.
trials take time. especially with a new segment in the market.
thoratec , screened 2800 patients , enrolled only 1 ( trial started before out trial ) and was stopped by the fda. same thoratec who was sold for $3.5 b
I still stand with my view that Rosa did a good job. price wise its shambolic. but dont tell me he has superpowers to decide who buys and sells.
fda approves interim analysis this barely moves.
fda suspends trial . down from 5.3 to 3.6
fda resumes trial - stock barely moves
finance uncertainty moves this from high 2s to 1s.
finance situation ammended , stock falls.
my point : a stock can be manipulated this way and were not the first biotech to fall for these methods. internal board power struggle ? could be.
why was ceo paid handsomely to leave ?
why did svb agree to amend the agreement when they had ssh by their balls ?
fundamentals - data - research - development - regulatory process
these are the most important areas. if they are good and continue to improve , we will be fine.
seen stocks go 4-5-10 folds in a matter of days or weeks. why wouldnt that happen to us ?
my advice is , if you can buy , its worth the risk . we have said that its a good buying opportunity since this was at $6
even if we fell and fell , it doesnt negate the fact that its still a great opportunity.
in an ideal world , we would all enter at these levels. but difficult situations arise and we wasted a year.
we could still fall more. but there will come a turning point.
also - if a big player knows that this is going bannanas , theyd hike the price up big time then bail.
it wouldnt be done this way.
again , not impressed with how things are going. the silence. the internal struggles. but hoping for the best.
* the $0.31 bid everyday which shows up at the end of trading , dont know why but have a feeling we will hit that. I just dont have the stomach to sell my shares and risk buying it at a lower price.
- Forums
- ASX - By Stock
- Mr John Erb
agree with jasonaz in any loan transaction , especially with a...
Featured News
Add SHC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online